As the slow drip continues, let's update the current valuation. The cash balance must be close to 220 million, the interest rate and currency exchange rate are exceptionally favorable. Of course, Clinuvel continues to carry $0 debt. Backing the cash out of the hilarious $11.54 share price, we're left with about $7.15 in premium for a company set to earn 84 cents per share in fiscal 2025. That's a P/E of 8.5. No..not 85, as is common with companies that have explosive growth prospects...8.5. Using a 17% growth forecast over the next 5 years, the PEG is .5
Find me another company with similar valuation metrics. Good luck. Yet somehow the "shorts" see opportunity to the downside from here. Bullshit. Fixed, scripted game.
CUV Price at posting:
$11.54 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)